Trial Details

COMPLETED
Basic Information
Clinical ID c3017
Identifier NCT02632175
Trial Title Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions BIOLOGICAL: Adalimumab
Participant Information
Sponsor AbbVie
City Orlando
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2015-11-26
Primary Completion Date 2025-04-08
Completion Date 2025-04-08